Artificial Intelligence driven Marketing Communications
Fortune Business Insights has published a premium research report on, titled ‘Prothrombin Complex Concentrate (PCC) Market Size, Share and Global Trend by Product Type (3-factor PCC, 4-factor PCC), Application (Congenital and Acquired Coagulation Factor deficiency), End User (Hospitals, Ambulatory Surgical Centers) and Geography Forecast till 2025. In this report. The Global PCC Market is likely to gain traction due to the significant drop in demand for its counterpart fresh frozen plasma (FFP).
Browse Complete Report Details at
Fortune Business Insights has predicted that this market, which was valued at US$536.3 Mn in 2017, reach US$ 1,076.5 Mn and in doing so, it will exhibit a CAGR of exhibiting a CAGR of 9.1%.
List of key companies mentioned in PCC market report;
Clinical studies have proven that fresh frozen plasma needed much longer infusion time, as compared to prothrombin complex concentrate (PCC). Besides infusion time, PCC possess some other advantages over FFP.
Some notable properties that have led to PCC’s increasing adoption are its ability to reconstitute in a short span. Furthermore, PCC is available easily due to its lack of blood group specificity. In addition to the aforementioned factors, a better safety profile of PCC has influenced users to prefer them over fresh frozen plasma.
“Leading Companies Are Focusing On Setting Up Plasma Collection Centres”
As companies are realizing the clinical advantages of PCC over fresh frozen plasma, they are now focusing on research and development of PCC. It is seen that there is an emphasis on stocking up plasma from blood that is required in PCC.
Get Sample PDF Brochure at
To ensure that these needs are sufficed, leading companies such as Grifols SA and Octapharma are putting in increased efforts towards setting up plasma collection centres across several countries around the world.
Major Segmentation include:
By Product Type
By End User
“Kcentra Has Changed the Face of PCC, Globally”
Ever since Kcentra was approved by the FDA, it has been adopted by many healthcare professionals worldwide. Kcentra has proven efficient in restoring blood coagulation, as it is packed with certain factors that help replenish various clotting factors. Kcentra played a major role in treatments for patients who are undergoing warfarin therapy.
Warfarin may lead to sever and acute blood loss and to minimize such losses and restoring coagulation factors, Kcentra has been proved beneficial. Therefore, the use of PCC in warfarin induced bleeding is leading to increased adoption which in turn has boosted the global market.
Order Complete Report at
“Increasing Government Initiatives and Funding to Boost the Global Market”
Recent updates in policies regarding usage approval have boded well for prothrombin complex concentrates. There has been a relaxation in usage of PCC in treating bleeding disorders, globally. This has encouraged research analysts and related personnel to conduct more clinical trials and propose newer usage concepts to the regulatory authorities. Moreover, increasing government funding promoting the use of PCC in surgical procedures is boosting the global market.
Proven clinical efficiency of PCC has encouraged governments across the world to promote the use of PCC for treating unwanted bleeding in surgical procedures. Furthermore, few alternatives are available to treat bleeding and the existing alternatives do not come close to the standards set by PCC. This in turn has led to an increase in demand for PCC and subsequently boosted the global PCC market.
Major Table of Content are;
1.4.Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.2. Market Restraints
4. Key Insights
4.1.Prevalence of Coagulation Factor Deficiency For Key Countries
4.2. Recent Industry Developments Partnerships, Mergers and Acquisitions4.3.Regulatory Scenario For Key Countries
4.4. Analysis in Relation to Alternatives to PCC
4.5.Global PCC Market: Reimbursement Scenario and Key Industry Trends
5. Global Prothrombin Complex Concentrate Market Analysis, Insights and Forecast,2014-2025
More Trending Topics from Fortune Business Insights:
U.S Secondary Hyperparathyroidism Treatment (SHPT) Market Size Worth USD 7.06 Billion by 2026; Increasing Launch of Effective Drugs Will Create Growth Opportunities
Carotenoids Market to Reach US$ 1.85 Billion by 2026, at a CAGR of 3.57 % | Fortune Business Insights
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune – 411045, Maharashtra, India.
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
Email: [email protected]
Press Release Distributed by The Express Wire
To view the original version on The Express Wire visit Prothrombin Complex Concentrate (PCC) Market 2019 | Comprehensive Analysis by Top Key Players with Size, Share, Trends and Forecast till 2026